115 related articles for article (PubMed ID: 23669350)
1. PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis.
Eschbach J; Schwalenstöcker B; Soyal SM; Bayer H; Wiesner D; Akimoto C; Nilsson AC; Birve A; Meyer T; Dupuis L; Danzer KM; Andersen PM; Witting A; Ludolph AC; Patsch W; Weydt P
Hum Mol Genet; 2013 Sep; 22(17):3477-84. PubMed ID: 23669350
[TBL] [Abstract][Full Text] [Related]
2. Decreased mRNA expression of PGC-1α and PGC-1α-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS.
Thau N; Knippenberg S; Körner S; Rath KJ; Dengler R; Petri S
J Neuropathol Exp Neurol; 2012 Dec; 71(12):1064-74. PubMed ID: 23147503
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome Proliferator Activator Receptor Gamma Coactivator-1α Overexpression in Amyotrophic Lateral Sclerosis: A Tale of Two Transgenics.
Varghese M; Zhao W; Trageser KJ; Pasinetti GM
Biomolecules; 2020 May; 10(5):. PubMed ID: 32414179
[TBL] [Abstract][Full Text] [Related]
4. ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.
Bayer H; Lang K; Buck E; Higelin J; Barteczko L; Pasquarelli N; Sprissler J; Lucas T; Holzmann K; Demestre M; Lindenberg KS; Danzer KM; Boeckers T; Ludolph AC; Dupuis L; Weydt P; Witting A
Neurobiol Dis; 2017 Jan; 97(Pt A):36-45. PubMed ID: 27818323
[TBL] [Abstract][Full Text] [Related]
5. Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis.
Russell AP; Wada S; Vergani L; Hock MB; Lamon S; Léger B; Ushida T; Cartoni R; Wadley GD; Hespel P; Kralli A; Soraru G; Angelini C; Akimoto T
Neurobiol Dis; 2013 Jan; 49():107-17. PubMed ID: 22975021
[TBL] [Abstract][Full Text] [Related]
6. PGC-1α protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model.
Liang H; Ward WF; Jang YC; Bhattacharya A; Bokov AF; Li Y; Jernigan A; Richardson A; Van Remmen H
Muscle Nerve; 2011 Dec; 44(6):947-56. PubMed ID: 22102466
[TBL] [Abstract][Full Text] [Related]
7. The role of PGC-1α in the pathogenesis of neurodegenerative disorders.
Róna-Vörös K; Weydt P
Curr Drug Targets; 2010 Oct; 11(10):1262-9. PubMed ID: 20840068
[TBL] [Abstract][Full Text] [Related]
8. Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS.
Da Cruz S; Parone PA; Lopes VS; Lillo C; McAlonis-Downes M; Lee SK; Vetto AP; Petrosyan S; Marsala M; Murphy AN; Williams DS; Spiegelman BM; Cleveland DW
Cell Metab; 2012 May; 15(5):778-86. PubMed ID: 22560226
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1α) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis.
Zhao W; Varghese M; Yemul S; Pan Y; Cheng A; Marano P; Hassan S; Vempati P; Chen F; Qian X; Pasinetti GM
Mol Neurodegener; 2011 Jul; 6(1):51. PubMed ID: 21771318
[TBL] [Abstract][Full Text] [Related]
10. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype.
Lambrechts D; Poesen K; Fernández-Santiago R; Al-Chalabi A; Del Bo R; Van Vught PW; Khan S; Marklund SL; Brockington A; van Marion I; Anneser J; Shaw C; Ludolph AC; Leigh NP; Comi GP; Gasser T; Shaw PJ; Morrison KE; Andersen PM; Van den Berg LH; Thijs V; Siddique T; Robberecht W; Carmeliet P
J Med Genet; 2009 Dec; 46(12):840-6. PubMed ID: 18413368
[TBL] [Abstract][Full Text] [Related]
12. Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner.
Russell LK; Mansfield CM; Lehman JJ; Kovacs A; Courtois M; Saffitz JE; Medeiros DM; Valencik ML; McDonald JA; Kelly DP
Circ Res; 2004 Mar; 94(4):525-33. PubMed ID: 14726475
[TBL] [Abstract][Full Text] [Related]
13. PGC-1alpha mediates exercise-induced skeletal muscle VEGF expression in mice.
Leick L; Hellsten Y; Fentz J; Lyngby SS; Wojtaszewski JF; Hidalgo J; Pilegaard H
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E92-103. PubMed ID: 19401459
[TBL] [Abstract][Full Text] [Related]
14. Effect of lifelong resveratrol supplementation and exercise training on skeletal muscle oxidative capacity in aging mice; impact of PGC-1α.
Ringholm S; Olesen J; Pedersen JT; Brandt CT; Halling JF; Hellsten Y; Prats C; Pilegaard H
Exp Gerontol; 2013 Nov; 48(11):1311-8. PubMed ID: 23994519
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex.
Witte ME; Nijland PG; Drexhage JA; Gerritsen W; Geerts D; van Het Hof B; Reijerkerk A; de Vries HE; van der Valk P; van Horssen J
Acta Neuropathol; 2013 Feb; 125(2):231-43. PubMed ID: 23073717
[TBL] [Abstract][Full Text] [Related]
16. Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome.
Alves CJ; de Santana LP; dos Santos AJ; de Oliveira GP; Duobles T; Scorisa JM; Martins RS; Maximino JR; Chadi G
Brain Res; 2011 Jun; 1394():90-104. PubMed ID: 21354109
[TBL] [Abstract][Full Text] [Related]
17. Suppression of retinal neovascularization by small interfering RNA targeting PGC-1α.
Zhang L; Jiang J; Xia X
Int J Mol Med; 2014 Jun; 33(6):1523-30. PubMed ID: 24682380
[TBL] [Abstract][Full Text] [Related]
18. PGC-1α activity in nigral dopamine neurons determines vulnerability to α-synuclein.
Ciron C; Zheng L; Bobela W; Knott GW; Leone TC; Kelly DP; Schneider BL
Acta Neuropathol Commun; 2015 Apr; 3():16. PubMed ID: 25853296
[TBL] [Abstract][Full Text] [Related]
19. Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease.
Clark J; Reddy S; Zheng K; Betensky RA; Simon DK
BMC Med Genet; 2011 May; 12():69. PubMed ID: 21595954
[TBL] [Abstract][Full Text] [Related]
20. The effects of PGC-1α on control of microvascular P(O2) kinetics following onset of muscle contractions.
Kano Y; Miura S; Eshima H; Ezaki O; Poole DC
J Appl Physiol (1985); 2014 Jul; 117(2):163-70. PubMed ID: 24833782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
